Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD7ME
|
||||
| Drug Name |
[2-(5-Fluoro-2-methoxy-phenoxy)-ethyl]-[2-(1H-indol-3-yl)-ethyl]-amine
|
||||
| Synonyms |
CHEMBL338482
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H21FN2O2
|
||||
| Canonical SMILES |
COc1ccc(F)cc1OCCNCCc2c[nH]c3ccccc23
|
||||
| InChI |
InChI=1S/C19H21FN2O2/c1-23-18-7-6-15(20)12-19(18)24-11-10-21-9-8-14-13-22-17-5-3-2-4-16(14)17/h2-7,12-13,21-22H,8-11H2,1H3
|
||||
| InChIKey |
PDGNKMACWXAEOS-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.